Navigation Links
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Date:3/19/2008

SAN DIEGO, March 19 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies announced today that InnerCool has entered into a distribution agreement with Lifehealthcare Pty Ltd., one of Australia's leading medical device distributors and healthcare service providers. Under terms of the agreement, Lifehealthcare will have exclusive marketing, sales and distribution rights in Australia and New Zealand for InnerCool's portfolio of temperature modulation systems. This agreement covers InnerCool's CoolBlue, a nurse-friendly and cost-effective surface cooling temperature modulation system, which was launched in the U.S. market during the fourth quarter 2007, as well as InnerCool's, premium-priced, high-performance RapidBlue endovascular cooling system, which is expected to be launched in the U.S. market in the second quarter 2008. RapidBlue is planned to be available for the New Zealand and Australia markets in the third quarter 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

"We are pleased to have this distribution agreement with Lifehealthcare. The company is establishing one of the finest medical equipment distribution networks in Australia and New Zealand and their sales force already has experience in selling temperature modulation products," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium Therapeutics and InnerCool Therapies. "Partnering with an experienced regional distributor is designed to accelerate the growth of InnerCool's temperature modulation business without the costs associated with developing our own international direct sales tea
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Current and Emerging Therapies Have No Advantage Over Pfizers Lyrica in Their Effect on Patients Quality of Life in the Treatment of Diabetic Neuropathy
2. Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market
3. New study of targeted therapies for breast cancer -- model for global clinical trials
4. FSU College of Medicine researcher seeks to uncover new cancer therapies
5. New Stroke Therapies Show Promise
6. Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients
7. Tailoring glioblastoma therapies: 1 size does not fit all
8. Integrated Laser Therapies Launches, Offers Low-power, Therapeutic Laser Devices and Training for Therapists and Consumers
9. Presidents Proposed 2009 Medicare Budget Would Weaken Seniors Access to Durable Medical Equipment and Therapies Required in the Home
10. New Therapies Could Change Organ Transplants
11. Pipeline for New Obesity Therapies is Focus of New Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...ording to a study conducted by Linda Chaudron, M.D...s and obstetrics and gynecology at the Medical Cen... fast rising among new mothers. The researcher sa... a period of 12 months after childbirth. Such an e...
...ording to a research done by Eyal Raz, Sandip Datt...a-San Diego School of Medicine it was found that g...e in inducing a protective immune response against...al Institute of Allergy and Infectious Diseases al...
... government of Japan has agreed to provide a grant...r the intensified pulse polio immunisation (IIPI) ...rmed Wednesday. Answering a question, Health and ...doss told the Lok Sabha: 'The grant will be utilis...
...overnment body issued a warning today that thousan...tially lethal doses of radiation.// The warning ... Ireland (RPII) came after a house in Kerry was di...d the acceptable level of the deadly radioactive a...
Other Medicine News:Health News:Early Diagnosis of Postpartum Depression Is Very Essential Among New Mothers 2Health News:Irish Households Exposed To Lethal Radiation 2
(Date:10/6/2008)... children, parents discussing clinical ...6 /PRNewswire-USNewswire/ -- From asthma and cance...es lives and improves their,health and well-being....alth (NIH), "Children and Clinical Studies", (http... offers parents and health,care providers an insid...
(Date:10/6/2008)...- Genaera,Corporation (Nasd...ase 1,clinical trial of trodusquemine (MSI-1436), ... type 2 diabetes and obesity. MSI-1436 is a novel,...hat controls the function,of both the leptin and i...appetite. In the study, MSI-1436 was found to be w...
(Date:10/6/2008)...ate 6 Weeks of Radiation Therapy -, Event: Watch S...ednesday, October 22, 2008, 3 - 4 p.m. by visit...ON, Va., Oct. 6 / Questions raced thr...breast cancer in May. Would she have the,tumor rem...chemotherapy?, , To view the Multimedia News Rel...
(Date:10/3/2008)...s the newest study site, PHILADELPHIA, Oct. 3 /PR... Philadelphia today received a contract to manage ... Children,s Hospital will manage local,participati...County, New,Jersey. The study is funded by the Nat...pate approximately 1,000 families in Burlington,Co...
Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2MedQuist Announces Additions to Board of Directors 7496 1MedQuist Announces Additions to Board of Directors 7496 2MedQuist Announces Additions to Board of Directors 7496 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 1BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 9Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 1Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 2Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 4Cyprus and Ireland Add Wyeths 7 Valent Pneumococcal Conjugate Vaccine 28PCV7 29 to Their National Immunisation Schedules 7491 1Cyprus and Ireland Add Wyeths 7 Valent Pneumococcal Conjugate Vaccine 28PCV7 29 to Their National Immunisation Schedules 7491 2Cyprus and Ireland Add Wyeths 7 Valent Pneumococcal Conjugate Vaccine 28PCV7 29 to Their National Immunisation Schedules 7491 3
...R, British Columbia--(BUSINESS WIRE)--May 23, 2007...d the results of,studies conducted by ITTEC Stem, ...ng results using AAGP(TM) in the cryopreservation,...tance of this,molecule in the rapidly expanding st...s using AAGP(TM) on human embryonic stem cells., U...
...-(BUSINESS WIRE)--May 22, 2007 - MIV Therapeutics,...t generation,biocompatible coatings and advanced d... other implantable medical devices, is,pleased to ...ng its,proprietary polymer free Hydroxyapatite-coa... Cypher Stent will be presented at,this weeks Euro...
Other Medicine Technology:ProtoKinetix's AAGP Dramatically Increases Recovery Rate of,Cryopreserved Stem Cells 2MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 2MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 3MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 4
...tem will define the state of knee implants. Now, f... requirements and increasing surgical options, whi...ons. The GENESIS II femoral components meet these...tomeet todays surgical demands. Clinical issues su...
Cruciate retaining, posterior stabilized and constrained components.
...tmental total knee prosthesis stems from many year...he-art design and manufacturing technologies have ...l function as well as a favorable pressure distrib... keep wear to a minimum. The inherent design of th...
Offset Liners - Plus 5 mm Neutral
Medicine Products: